中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
4期
38-40
,共3页
支原体肺炎%患儿%普米克令舒%阿奇霉素
支原體肺炎%患兒%普米剋令舒%阿奇黴素
지원체폐염%환인%보미극령서%아기매소
Mycoplasma pneumonia%Children%Pulmicort%Azithromycin
目的：探讨和分析普米克令舒联合阿奇霉素治疗儿童肺炎支原体感染的疗效观察。方法：从本院2012年12月-2013年12月收治的支原体肺炎患儿中随机抽取102例作为本次研究对象，按随机双盲法将102例患儿分为观察组与对照组，对照组患儿51例，采用阿奇霉素对其进行治疗，观察组患儿51例在对照组的治疗基础上加入普米克令舒，观察两组患儿的临床疗效、住院时间、病症消失时间、不良反应。结果：观察组患儿治愈率与总效率分别为52.94%（27例）、94.11%（48例），明显高于对照组的31.37%（16例）、80.39%（41例），比较差异有统计学意义（P<0.05）。观察组患儿住院时间、病症消失时间及不良反应明显低于对照组，比较差异有统计学意义（P<0.05）。结论：普米克令舒联合阿奇霉素治疗儿童支原体肺炎疗效显著，且住院时间及不良反应都较少，得到了患儿家属的一致好评，值得在临床上进行推广并应用。
目的：探討和分析普米剋令舒聯閤阿奇黴素治療兒童肺炎支原體感染的療效觀察。方法：從本院2012年12月-2013年12月收治的支原體肺炎患兒中隨機抽取102例作為本次研究對象，按隨機雙盲法將102例患兒分為觀察組與對照組，對照組患兒51例，採用阿奇黴素對其進行治療，觀察組患兒51例在對照組的治療基礎上加入普米剋令舒，觀察兩組患兒的臨床療效、住院時間、病癥消失時間、不良反應。結果：觀察組患兒治愈率與總效率分彆為52.94%（27例）、94.11%（48例），明顯高于對照組的31.37%（16例）、80.39%（41例），比較差異有統計學意義（P<0.05）。觀察組患兒住院時間、病癥消失時間及不良反應明顯低于對照組，比較差異有統計學意義（P<0.05）。結論：普米剋令舒聯閤阿奇黴素治療兒童支原體肺炎療效顯著，且住院時間及不良反應都較少，得到瞭患兒傢屬的一緻好評，值得在臨床上進行推廣併應用。
목적：탐토화분석보미극령서연합아기매소치료인동폐염지원체감염적료효관찰。방법：종본원2012년12월-2013년12월수치적지원체폐염환인중수궤추취102례작위본차연구대상，안수궤쌍맹법장102례환인분위관찰조여대조조，대조조환인51례，채용아기매소대기진행치료，관찰조환인51례재대조조적치료기출상가입보미극령서，관찰량조환인적림상료효、주원시간、병증소실시간、불량반응。결과：관찰조환인치유솔여총효솔분별위52.94%（27례）、94.11%（48례），명현고우대조조적31.37%（16례）、80.39%（41례），비교차이유통계학의의（P<0.05）。관찰조환인주원시간、병증소실시간급불량반응명현저우대조조，비교차이유통계학의의（P<0.05）。결론：보미극령서연합아기매소치료인동지원체폐염료효현저，차주원시간급불량반응도교소，득도료환인가속적일치호평，치득재림상상진행추엄병응용。
Objective:To discuss and analyze Pulmicort Respules combined with azithromycin clinical observation on the treatment of Mycoplasma pneumoniae infection in children.Method:102 cases with mycoplasma pneumonia were randomly selected in our hospital from 2012 December to 2013 December period as the object of study, according to the random double blind method,102 patients were divided into observation group and control group,control group contained 51 cases,using azithromycin,the observation group contained 51 cases added Pulmicort treatment on the basis of the control group,the clinical efficacy after treatment of the two groups was observed,as well as hospitalization time,symptoms disappear time,adverse reaction.Result:The cure rate and total effective rate of the observation group was 52.94%(27 cases),94.11%(48 cases)respectively,which was significantly higher than 31.37%(16 cases), 80.39%(41 cases)of the control group,there were statistically significant differences(P<0.05).The hospitalization time,symptoms disappeared time,and adverse reactions of the observation group was lower than that of the control group, there were statistically significant differences(P<0.05).Conclusion:Pulmicort Respules combined with azithromycin in treatment of children with mycoplasma pneumonia has curative effect,and the hospitalization time and adverse reactions are less,get favorable comments from the families of the children,worthy of promotion and application in clinical.
